FDA NDC Directory · JSON-LD · Markdown

Briviact

NDC 50474-970 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION

Generic namebrivaracetam
Labeler / ManufacturerUCB, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA205837
Dosage form / routeINJECTION, SUSPENSION · INTRAVENOUS
Active ingredientsBRIVARACETAM (50 mg/5mL)
Marketing started20160512
Package count1

External sources

Source: openFDA. Public-domain (CC0).